Fresh Legislative and Clinical Push to Tackle Cardiovascular Disease in France
Efforts to combat cardiovascular disease are intensifying with new legislative proposals and national clinical experiments aimed at accelerating prevention and improving patient outcomes. On April 1, 2026, a bill was proposed by Yannick Neuder and several colleagues to accelerate cardio-neuro-vascular prevention, seeking to anticipate a major social and health risk.
Parallel to these legislative efforts, a national experiment known as Cardio+ is currently underway to modernize the follow-up care for patients who have experienced cardiac events. Carried out under Article 51 and supported by the Health System Innovation Fund (FISS), the project aims to strengthen prevention, improve care coordination, and reduce the rate of re-hospitalizations. The initiative is led by the National Syndicate of Cardiologists and, within the Auvergne-Rhône-Alpes region, involves the University Hospital Center (CHU) of Grenoble, the Vichy Hospital Center, and private cardiologists. The project, which targets 12,150 adult patients, is scheduled to run until 2028 and is being deployed in the Ain, Allier, and Haute-Loire territories.
A critical component of these public health efforts is addressing the gender gap in cardiovascular care. Experts are emphasizing that lifelong cardiovascular screening must become a priority for women. This urgency is underscored by ongoing health inequalities, with medical professionals warning that women must be educated to recognize that chest pain can be a sign of a heart attack. In response, the Groupement Hospitalier des Alpes du Sud has issued a call for women to prioritize their heart health.
The necessity of rapid intervention and accurate diagnosis is highlighted by extreme clinical cases, such as a woman from Sarthe who experienced a heart rate of 256 beats per minute, illustrating the life-threatening nature of cardiovascular emergencies.
These combined legislative and clinical strategies highlight a growing effort to bridge gaps in cardiovascular care and reduce preventable hospitalizations through earlier detection and more coordinated follow-up.